Like most websites The Pathologist uses cookies. In order to deliver a
personalized, responsive service and to improve the site, we remember and store information about how you use
it.
Learn more.
Congratulations! You now have unlimited access to all articles from The Pathologist.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
This microfluidic chip is designed to analyze urine for the presence of prostate cancer cells. Developed at Russia’s Sechenov University, the chip separates large cancer cells from smaller, lighter benign cells present in urine. In pilot experiments, the chip correctly detected prostate cancer in 12 of 14 patients and confirmed its absence in 11 of 14 healthy volunteers.
Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
About the AuthorMichael Schubert
While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.
